Germline structural variant as the cause of Lynch Syndrome in a family from Ecuador
- PMID: 39821083
- PMCID: PMC11739559
- DOI: 10.1038/s41525-025-00462-y
Germline structural variant as the cause of Lynch Syndrome in a family from Ecuador
Abstract
Colorectal cancer (CRC) is one of the most common cancers worldwide. Lynch Syndrome (LS) is the most common form of hereditary CRC and it is caused by germline defects in the DNA-mismatch repair (MMR) pathway. It is of extreme importance for affected LS patients and their relatives to identify the germline causative alteration to provide intensified surveillance to those at risk and allow early diagnosis and cancer prevention. Current approaches for LS molecular diagnosis typically involve screening of the MMR genes by targeted gene-panel sequencing and rearrangement screening. We report the identification and characterization of a novel germline structural variant encompassing 48.757 kb, involving the 3'-ends of the MLH1 and LRRFIP2 genes, as the cause of LS in a family of Ecuador. Whole-genome sequencing and transcriptomics allowed the identification of the genomic rearrangement and highlights the importance of the use of these additional approaches to achieve a comprehensive molecular diagnosis in some LS patients.
© 2025. The Author(s).
Conflict of interest statement
Competing interests: The authors declare no competing interests.
Figures
References
Grants and funding
- PRYGN211085CAST/Fundación Científica Asociación Española Contra el Cáncer (Scientific Foundation, Spanish Association Against Cancer)
- PRYGN211085CAST/Fundación Científica Asociación Española Contra el Cáncer (Scientific Foundation, Spanish Association Against Cancer)
- 20/00113, 23/00189/Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (Institute of Health Carlos III)
- CIBEREHD/Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (Institute of Health Carlos III)
- CIBEREHD/Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (Institute of Health Carlos III)
- 22/00470/Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (Institute of Health Carlos III)
- 202008-10/Fundació la Marató de TV3 (TV3 Marathon Foundation)
- 202008-10/Fundació la Marató de TV3 (TV3 Marathon Foundation)
- COST Action CA17118/European Cooperation in Science and Technology (COST)
- Translational Oncology program/"la Caixa" Foundation (Caixa Foundation)
- Translational Oncology program/"la Caixa" Foundation (Caixa Foundation)
- CERCA program/Departament d'Innovació, Universitats i Empresa, Generalitat de Catalunya (Department of Innovation, Education and Enterprise, Government of Catalonia)
- 2021 SGR 01185/Departament d'Innovació, Universitats i Empresa, Generalitat de Catalunya (Department of Innovation, Education and Enterprise, Government of Catalonia)
- 2021 SGR 00716/Departament d'Innovació, Universitats i Empresa, Generalitat de Catalunya (Department of Innovation, Education and Enterprise, Government of Catalonia)
- CERCA program/Departament d'Innovació, Universitats i Empresa, Generalitat de Catalunya (Department of Innovation, Education and Enterprise, Government of Catalonia)
- STEPUPIORS/EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020)
LinkOut - more resources
Full Text Sources
